Mass Balance, Metabolite Profile, andIn Vitro-In VivoComparison of Clearance Pathways of Deleobuvir, a Hepatitis C Virus Polymerase Inhibitor
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.03861-14
Full Text
Open PDFAbstract
Available in full text
Date
October 13, 2014
Authors
Publisher
American Society for Microbiology